Preserving a person is the half of cryonics we can do today. Reversing it is the half we cannot, and it is worth being precise about why, because "we cannot reverse it yet" covers several distinct problems, some closer to solved than others. This article walks through the technical barriers to reversible cryopreservation, the ones that stand between a well-preserved patient and a living one. It is the honest companion to why revival is currently not possible.
Rewarming is harder than cooling
The first surprise is that warming is the dangerous direction. Cooling can be done relatively slowly and carefully; rewarming has to be done fast. A single cell can be rewarmed in under a minute in a warm bath, and speed is essential because slow rewarming gives ice a second chance to form. As a vitrified sample warms back through the danger zone, the glass can partially crystallize, a process called devitrification or recrystallization, undoing exactly what vitrification achieved. For a single cell or a thin sample this is manageable. For a whole human, it is not yet possible at all.
The whole-organ problem: warming evenly
The reason scale matters so much is uniformity. A large, complex object does not warm evenly: the outside heats faster than the inside, and different tissues at different rates. Wherever a region lags, it can pass back through the temperature where ice forms while neighboring regions are already safe. So the central challenge is not just warming fast but warming the entire volume fast and uniformly. This is an active research frontier. One promising approach uses high-intensity focused ultrasound to rewarm a sample rapidly and evenly, and the broader idea of "nanowarming," seeding tissue with nanoparticles that can be heated uniformly from within, is being pursued precisely to solve this problem.
Undoing the toxicity
There is a deeper reason rewarming is hard. The cryoprotectants that make preservation possible are harmless at cryogenic temperatures, where all chemistry is paused, but toxic once things warm up. To revive someone you would have to remove those agents quickly and cleanly as you rewarm, before they can harm the tissue, and do it uniformly across the whole body. No technique exists today to do that at human scale. It is one of the central unsolved problems of the field, and an honest provider names it rather than glossing over it.
And then the original problem is still there
Even granting perfect rewarming and detoxification, you would be left with the patient's original condition: the disease or injury that caused legal death, plus whatever ischemic and preservation damage accumulated along the way. Reversal in the full sense means repairing all of it. That is why serious thinking about revival reaches for technologies that do not yet exist. The most detailed roadmap, Robert Freitas and Greg Fahy's Cryostasis Revival, sketches two broad routes: a "conventional" one that scans the vitrified structure, then extracts cryoprotectant and uses molecular machines to repair tissue during rewarming, and a more radical "molecular reconstruction" that maps the brain atom by atom and rebuilds from that map. Both are firmly future technology, and both connect to the nanotechnology bet.
What is and is not already proven
It would be dishonest to imply reversal is purely hypothetical at every scale. A rabbit kidney has been vitrified, rewarmed, transplanted, and shown to function, a genuine whole-organ round trip. And recent work has shown functional recovery of brain tissue after vitrification. These are real milestones. The gap to a whole human is still vast, spanning size, complexity, and the need to repair the cause of death, but the direction of travel is from "impossible" toward "hard," one scale at a time.
Reversible cryopreservation is not one locked door but several: rewarm fast and evenly, strip the toxicity cleanly, and repair both the preservation damage and the original cause of death. We have opened the first locks at small scale. The whole-human set remains future work, and we say so plainly.